News

May 18, 2023
Laura Teschner
May 18, 2023

Laura Teschner Joins Headlands Research as Chief People Officer
Read More
May 4, 2023
A photo of employees from Clinvest Research smile at the camera. The Clinvest logo sits above the text "Our site network’s growth momentum marches on with Missouri!"
May 4, 2023

Headlands Research Acquires Clinvest Research — the Clinical Research Site Network’s Third Addition of 2023
Read More
April 18, 2023
April 18, 2023

Headlands Research Acquires Established Eastern Massachusetts–Based Research Site Specializing in Neurodegenerative Diseases
Read More
March 23, 2023
Headlands Research Detroit
March 23, 2023

Headlands Research Deepens Diversity and Expands Network with Launch of Metro Detroit–Based Clinical Trial Site
Read More
December 5, 2022
December 5, 2022

Lecanemab Represents Promising Therapy for Alzheimer Disease
Read More
December 1, 2022
December 1, 2022

Dr. Sharon Cohen Discusses Alzheimer’s in Canada on the Social CTV
Read More
November 10, 2022
November 10, 2022

Headlands Research CEO Mark Blumling Joins SCRS Talks to Discuss Collaborating for Site Sustainability: The Ins & Outs of Site Networks
Read More
November 3, 2022
November 3, 2022

First Patient Dosed in Clairvoyant’s Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder
Read More
June 30, 2022
June 30, 2022

Headlands Research Further Expands its Leading Clinical Research Site Network by Acquiring Peninsula Research Associates
Read More
May 25, 2022
TMP Press Release
May 25, 2022

Headlands Research’s Toronto Memory Program site and RetiSpec Awarded Grant to Launch Innovative Early Detection Program for Alzheimer’s
Read More